Agilent Technologies Inc Revenue Growth Rates (A), Current and Historic Growth - CSIMarket
CSIMarket
 


Agilent Technologies inc   (NYSE: A)
 

A's Revenue Growth by Quarter and Year

Agilent Technologies Inc 's Revenue results by quarter and year




A Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter October -
3rd Quarter July 1,878.00
2nd Quarter April 1,835.00
1st Quarter January 1,798.00
FY 5,511.00

As Annual Revenue
Agilent Technologies Inc 's Revenue in the fiscal year 2025 $ 6,948.00 millions
Agilent Technologies Inc 's Revenue in the fiscal year 2024 $ 6,510.00 millions
Agilent Technologies Inc 's Revenue in the fiscal year 2023 $ 6,833.00 millions
Agilent Technologies Inc 's Revenue in the fiscal year 2022 $ 6,848.00 millions
Agilent Technologies Inc 's Revenue in the fiscal year 2021 $ 6,319.00 millions




A Revenue third quarter 2026 Y/Y Growth Comment
Agilent Technologies inc achieved in the third quarter 2026, above Company average Revenue improvement of 8.06% year on year, to $ 1,878.00 millions.

Looking into third quarter 2026 results within Laboratory Analytical Instruments industry 11 other companies have achieved higher Revenue growth. While Agilent Technologies Inc ' s Revenue increase of 8.06% ranks overall at the positon no. 2334 in the third quarter 2026.




A Revenue ( Y/Y Growth %) 2026
2025 2024 2023
4th Quarter October - 10.31 % -0.06 % -8.71 %
3rd Quarter July 8.06 % 10.14 % -5.62 % -2.68 %
2nd Quarter April 10.01 % 6.04 % -8.39 % 6.85 %
1st Quarter January 6.96 % 1.39 % -5.58 % 4.9 %
FY   - 6.96 % -4.93 % -

Financial Statements
Agilent Technologies Inc 's third quarter 2026 Revenue $ 1,878.00 millions A's Income Statement
Agilent Technologies Inc 's third quarter 2025 Revenue $ 1,738.00 millions Quarterly A's Income Statement


A Revenue (Quarter on Quarter Growth %)

2026
2025 2024 2023
4th Quarter October - 7.08 % 6.91 % 0.96 %
3rd Quarter July 2.34 % 4.2 % 0.32 % -2.62 %
2nd Quarter April 2.06 % -0.77 % -5.13 % -2.22 %
1st Quarter January -3.39 % -0.36 % -1.78 % -5.03 %
FY (Year on Year)   - 6.96 % -4.93 % -




Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #12
Healthcare Sector #340
Overall #2334

Revenue Y/Y Growth Statistics
High Average Low
30.76 % 2.03 % -30.86 %
(April 30, 2011)   (July 31, 2014)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #12
Healthcare Sector #340
Overall #2334
Revenue Y/Y Growth Statistics
High Average Low
30.76 % 2.03 % -30.86 %
(April 30, 2011)   (July 31, 2014)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Agilent Technologies Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
103.25 % 1.43 % -50.12 %
(Oct 31 2015)  


A's III. Quarter Q/Q Revenue Comment
Agilent Technologies inc achieved in the III. Quarter 2026 above company average sequential Revenue growth of 2.34%, to $ 1,878.00 millions, from $1,835.00 millions in the second quarter.

Within Laboratory Analytical Instruments industry 3 other companies have achieved higher Revenue quarter on quarter growth. While Agilent Technologies Inc 's Revenue growth quarter on quarter, overall rank is 1433.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #4
Healthcare Sector #197
Overall #1433
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #4
Healthcare Sector #197
Overall #1433
Revenue Q/Q Growth Statistics
High Average Low
103.25 % 1.43 % -50.12 %
(Oct 31 2015)  


A's III. Quarter Q/Q Revenue Comment
Agilent Technologies inc achieved in the III. Quarter 2026 above company average sequential Revenue growth of 2.34%, to $ 1,878.00 millions, from $1,835.00 millions in the second quarter.

Within Laboratory Analytical Instruments industry 3 other companies have achieved higher Revenue quarter on quarter growth. While Agilent Technologies Inc 's Revenue growth quarter on quarter, overall rank is 1433.


Agilent Technologies Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jul 31 2026)
12 Months Ending
(Apr 30 2026)
12 Months Ending
(Jan 31 2026)
12 Months Ending
(Oct 31 2025)
12 Months Ending
(Jul 31 2025)
Cumulative Revenue 12 Months Ending $ 7,372.00 $ 7,232.00 $ 7,065.00 $ 6,948.00 $ 6,774.00
Y / Y Revenue Growth (TTM) 8.83 % 9.34 % 8.38 % 6.96 % 4.26 %
Year on Year Revenue Growth Overall Ranking # 2130 # 2357 # 1927 # 2647 # 2655
Seqeuential Revenue Change (TTM) 1.94 % 2.36 % 1.68 % 2.57 % 2.42 %
Seq. Revenue Growth (TTM) Overall Ranking # 2334 # 2178 # 1680 # 2163 # 2302


Cumulative Revenue growth Comment
Assuming the Agilent Technologies Inc 's fiscal year would have ended in Jul 31 2026, Agilent Technologies Inc would have reprted above average annual Revenue improvement of 8.83% year on year, of $ 7,372 millions.
This marks a slow-down of the companys growth trends and from the 9.34% growth in Apr 30 2026.

In the Healthcare sector 320 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2130, from total ranking in previous quarter at 2357.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 12
Healthcare Sector # 321
Overall # 2130

Revenue TTM Y/Y Growth Statistics
High Average Low
30.76 %
2.03 %
-30.86 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 340
S&P 500 # 2334
Cumulative Revenue growth Comment
Assuming the Agilent Technologies Inc 's fiscal year would have ended in Jul 31 2026, Agilent Technologies Inc would have reprted above average annual Revenue improvement of 8.83% year on year, of $ 7,372 millions.
This marks a slow-down of the companys growth trends and from the 9.34% growth in Apr 30 2026.

In the Healthcare sector 320 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2130, from total ranking in previous quarter at 2357.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 12
Healthcare Sector # 321
Overall # 2130

Revenue TTM Y/Y Growth Statistics
High Average Low
30.76 %
2.03 %
-30.86 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 340
S&P 500 # 2334




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
A's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Jul 31 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jul 31 2026
Medtronic Plc13.73%$ 13.733 millions
Exelixis Inc 10.63%$ 10.634 millions
Heartsciences Inc 10.53%$ 10.526 millions
Champions Oncology Inc 8.84%$ 8.839 millions
Agilent Technologies inc 8.06%$ 8.055 millions


About Agilent Technologies Inc Revenue Growth Rates (A), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Agilent Technologies Inc (CIK 1090872).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001090872-26-000064
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Agilent Technologies Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.